| Fresenius Medical Care Executes Exclusive Interface Biologics License Agreement - MarketWatch (press release) |
|
|
MarketWatch (press release) In July of 2010, IBI announced the signing of a definitive license and supply agreement whereby Fresenius Medical Care was offered exclusive worldwide license to apply IBI's Endexo(TM) technology to various components of their dialysis circuits for |